ATRA
Price
$13.85
Change
+$0.11 (+0.80%)
Updated
Sep 29, 12:58 PM (EDT)
Capitalization
96.5M
MOLN
Price
$3.85
Change
+$0.24 (+6.65%)
Updated
Sep 26 closing price
Capitalization
130.6M
31 days until earnings call
Interact to see
Advertisement

ATRA vs MOLN

Header iconATRA vs MOLN Comparison
Open Charts ATRA vs MOLNBanner chart's image
Atara Biotherapeutics
Price$13.85
Change+$0.11 (+0.80%)
Volume$100
Capitalization96.5M
Molecular Partners AG
Price$3.85
Change+$0.24 (+6.65%)
Volume$2.75K
Capitalization130.6M
ATRA vs MOLN Comparison Chart in %
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. MOLN commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Buy and MOLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ATRA: $13.74 vs. MOLN: $3.85)
Brand notoriety: ATRA and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 68% vs. MOLN: 80%
Market capitalization -- ATRA: $96.5M vs. MOLN: $130.6M
ATRA [@Biotechnology] is valued at $96.5M. MOLN’s [@Biotechnology] market capitalization is $130.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 1 FA rating(s) are green whileMOLN’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 1 green, 4 red.
  • MOLN’s FA Score: 0 green, 5 red.
According to our system of comparison, ATRA is a better buy in the long-term than MOLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 4 TA indicator(s) are bullish while MOLN’s TA Score has 7 bullish TA indicator(s).

  • ATRA’s TA Score: 4 bullish, 4 bearish.
  • MOLN’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, MOLN is a better buy in the short-term than ATRA.

Price Growth

ATRA (@Biotechnology) experienced а +14.02% price change this week, while MOLN (@Biotechnology) price change was +2.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.07%. For the same industry, the average monthly price growth was +11.19%, and the average quarterly price growth was +59.65%.

Reported Earning Dates

MOLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($131M) has a higher market cap than ATRA($96.5M). ATRA YTD gains are higher at: 3.231 vs. MOLN (-18.981). ATRA has higher annual earnings (EBITDA): 14.3M vs. MOLN (-62.52M). MOLN has more cash in the bank: 114M vs. ATRA (22.3M). MOLN has less debt than ATRA: MOLN (1.84M) vs ATRA (17.7M). ATRA has higher revenues than MOLN: ATRA (189M) vs MOLN (681K).
ATRAMOLNATRA / MOLN
Capitalization96.5M131M74%
EBITDA14.3M-62.52M-23%
Gain YTD3.231-18.981-17%
P/E Ratio19.08N/A-
Revenue189M681K27,753%
Total Cash22.3M114M20%
Total Debt17.7M1.84M964%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
29
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRAMOLN
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 11 days ago
69%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 18 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMREF0.150.01
+8.42%
Sun Summit Minerals Corp
SOAGY45.990.29
+0.63%
Sartorius AG
YECO0.10N/A
N/A
Yulong Eco-Materials Limited
GYYMF2.00N/A
N/A
Gym Group PLC.
FCXXF13.96N/A
N/A
First Cap Real Estate Investment Trust

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
+6.60%
SNSE - MOLN
39%
Loosely correlated
+0.34%
SLDB - MOLN
36%
Loosely correlated
+3.89%
RCKT - MOLN
33%
Poorly correlated
+2.19%
ATRA - MOLN
31%
Poorly correlated
-0.65%
RAPT - MOLN
30%
Poorly correlated
+7.89%
More